Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1α pathway

Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1α pathway

Bibliographic Details
Main Authors:	Rana, S, Rajakumar, A, Geahchan, C, Salahuddin, S, Cerdeira, AS, Burke, SD, George, EM, Granger, JP, Karumanchi, SA
Format:	Journal article
Language:	English
Published:	FASEB 2014

Similar Items

Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia
by: Ai-ris Yonekura Collier, et al.
Published: (2019-07-01)

Chemical optimization of siRNA for safe and efficient silencing of placental sFLT1
by: Sarah M. Davis, et al.
Published: (2022-09-01)

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
by: Kyle H. Moore, et al.
Published: (2020-06-01)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
by: Lei Li, et al.
Published: (2020-02-01)

Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
by: Anna Maria Nuzzo, et al.
Published: (2021-01-01)

sFlt-1 Levels as a Predicting Tool in Placental Dysfunction Complications in Multiple Pregnancies
by: Valentina Giardini, et al.
Published: (2023-10-01)

Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia
by: Laura Ehrlich, et al.
Published: (2017-04-01)

sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01)

Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients
by: Xiaohe Zhu, et al.
Published: (2020-10-01)

Circulating SFLT-1 is placentally derived in normal pregnancy
by: Cerdeira, A, et al.
Published: (2018)

Carbon monoxide prevents hypertension and proteinuria in an adenovirus sFlt-1 preeclampsia-like mouse model.
by: Carolina C Venditti, et al.
Published: (2014-01-01)

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
by: Ioakeim Sapantzoglou, et al.
Published: (2023-06-01)

sFlt-1 in Chronic Kidney Disease: Friend or Foe?
by: Masaru Matsui, et al.
Published: (2022-11-01)

Overexpression of Human sFLT1 in the Spongiotrophoblast Is Sufficient to Induce Placental Dysfunction and Fetal Growth Restriction in Transgenic Mice
by: Rebekka Vogtmann, et al.
Published: (2024-02-01)

Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy
by: Evangeline Deer, et al.
Published: (2021-10-01)

Correlation between uterine artery Doppler and the sFlt-1/PlGF ratio in different phenotypes of placental dysfunction
by: Vesna Fabjan-Vodusek, et al.
Published: (2019-01-01)

Performance of sFlt-1/PlGF ratio ≥85 for ruling in preeclampsia within 4 weeks
by: Cerdeira, AS, et al.
Published: (2020)

Low-molecular weight heparin increases circulating sFlt-1 levels and enhances urinary elimination.
by: Henning Hagmann, et al.
Published: (2014-01-01)

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
by: Kifle, MM, et al.
Published: (2022)

Human endometrial stromal cell plasticity: Reversible sFlt1 expression negatively coincides with decidualization
by: Hanh N. Cottrell, et al.
Published: (2017-04-01)

Soyghurt Potentially Controls the Level of sFlt1 and PLGF in Preeclampsia Maternal Serum-Induced Placental Trophoblast Cell in vitro
by: Khairani AF, et al.
Published: (2024-03-01)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
by: Anca-Florina Tataru-Copos, et al.
Published: (2022-09-01)

Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1
by: Hiroaki Tanaka, et al.
Published: (2022-06-01)

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
by: Meron M. Kifle, et al.
Published: (2022-06-01)

Reduced expression in preterm birth of sFLT-1 and PlGF with a high sFLT-1/PlGF ratio in extracellular vesicles suggests a potential biomarker
by: Sama Hussein, et al.
Published: (2022-12-01)

The sFlt-1/PlGF Ratio at 12, 24, and 32 Weeks Gestation in Twin Pregnancies as a Predictor of Placental Dysfunction
by: Elena Satorres-Pérez, et al.
Published: (2024-03-01)

Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies
by: Alice Hoeller, et al.
Published: (2017-04-01)

Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice.
by: Gabor Szalai, et al.
Published: (2015-01-01)

How sFlt-1 can help after pre-eclampsia diagnosis
by: Rolnik, DL, et al.
Published: (2020)

Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa
by: Na Wang, et al.
Published: (2021-01-01)

MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia
by: Qing Yong, et al.
Published: (2023-06-01)

Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia
by: Ping Tang, et al.
Published: (2017-01-01)

A simple detection method for the serum sFLT1 protein in preeclampsia
by: Masabumi Shibuya, et al.
Published: (2021-10-01)

Altered Level of Soluble fms-like Tyrosine Kinase 1 (sFlt1) and Hypoxia Inducible Factor-1alpha (HIF-1alpha) in Normotensive Pregnancy and Preeclampsia
by: John Wantania, et al.
Published: (2013-08-01)

Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.
by: Robert W Powers, et al.
Published: (2010-10-01)

Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.
by: Zeisler, H, et al.
Published: (2016)

Enhanced Serum Levels of sFlt1: Impact on Materno–Fetal CMV Transmission
by: Lukas Penka, et al.
Published: (2020-04-01)

The sFlt-1/PlGF Ratio in Pregnant Patients Affected by COVID-19
by: Katarzyna Kosinska-Kaczynska, et al.
Published: (2023-01-01)

Angiogenic factors (sFlt-1, PlGF) in twin pregnancy with placentaassociated complications
by: M. A. Kurtser, et al.
Published: (2022-11-01)

Predictive Value Analysis of Serum sFlt-1 and PLGF Levels/Ratio in Preeclampsia
by: Shuyuan Xue, et al.
Published: (2022-09-01)